CUSIP 002942100COMAARDQ4 2025
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradeQ4 2025
66 funds hold this security · Q4 2025
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Decheng Capital LLC | 3.92M | $51.41M | 0 | Held |
| 2 | Citadel Advisors LLC | 1.29M | $16.92M | −70.6K | Reduced |
| 3 | Laurion Capital Management LP | 1.01M | $13.32M | −34.8K | Reduced |
| 4 | Blackrock, Inc. | 784.4K | $10.30M |
| +475.0K |
| Added |
| 5 | Vanguard Group Inc | 717.4K | $9.42M | +161.7K | Added |
| 6 | Millennium Management LLC | 483.3K | $6.34M | +163.7K | Added |
| 7 | Symbiosis Capital Partners, LLC | 476.6K | $6.26M | +476.6K | New Position |
| 8 | Silverarc Capital Management, LLC | 303.9K | $3.99M | −3.0K | Reduced |
| 9 | Geode Capital Management, LLC | 297.9K | $3.91M | +103.8K | Added |
| 10 | State Street Corp | 158.2K | $2.08M | +65.2K | Added |
See every fund holding Aardvark Therapeutics Inc, with full quarter-over-quarter share changes.
Unlock all holders